SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-097051
Filing Date
2024-08-14
Accepted
2024-08-14 16:18:32
Documents
13
Period of Report
2024-08-14
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 8-K tsbx-20240806.htm   iXBRL 8-K 46644
2 EX-99.1 tsbx-ex99_1.htm EX-99.1 114145
3 EX-99.2 tsbx-ex99_2.htm EX-99.2 27457
  Complete submission text file 0000950170-24-097051.txt   324077

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20240806.xsd EX-101.SCH 26013
16 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20240806_htm.xml XML 4923
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 241208210
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)